Publications and communications of Victor LEGRAND

Dangas, G. D., Tijssen, J. G. P., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., Makkar, R. R., Herrmann, H. C., Giustino, G., Baldus, S., De Backer, O., Guimarães, A. H. C., Gullestad, L., Kini, A., von Lewinski, D., Mack, M., Moreno, R., Schäfer, U., Seeger, J., ... Castellant, P. (Other coll.). (09 January 2020). A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. New England Journal of Medicine, 382 (2), 120-129. doi:10.1056/NEJMoa1911425

Andelic, N., Røe, C., Brunborg, C., Zeldovich, M., Løvstad, M., Løke, D., Borgen, I. M., Voormolen, D. C., Howe, E. I., Forslund, M. V., Dahl, H. M., von Steinbuechel, N., Åkerlund, C., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., ... CENTER-TBI participants investigators. (2020). Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study. Journal of Neurology. doi:10.1007/s00415-020-10022-2

Gravesteijn, B. Y., Nieboer, D., Ercole, A., Lingsma, H. F., Nelson, D. W., van Calster, B., Steyerberg, E. W., Åkerlund, C., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., Azouvi, P., Azzolini, M. L., Bartels, R., Barzó, P., Beauvais, R., ... CENTER-TBI collaborators. (2020). Machine learning algorithms performed no better than regression models for prognostication in traumatic brain injury. Journal of Clinical Epidemiology, 122, 95-107. doi:10.1016/j.jclinepi.2020.03.005

Gravesteijn, B. Y., Sewalt, C. A., Nieboer, D., Menon, D. K., Maas, A., Lecky, F., Klimek, M., Lingsma, H. F., Åkerlund, C., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., Azouvi, P., Azzolini, M. L., Bartels, R., Barzó, P., ... Zoerle, T. (2020). Tracheal intubation in traumatic brain injury: a multicentre prospective observational study. British Journal of Anaesthesia. doi:10.1016/j.bja.2020.05.067

Timmers, M., Van Dijck, J. T. J. M., Van Wijk, R. P. J., Legrand, V., Van Veen, E., Maas, A. I. R., Menon, D. K., Citerio, G., Stocchetti, N., Kompanje, E. J. O., Åkerlund, C., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., Azouvi, P., Azzolini, M. L., ... Zoerle, T. (2020). How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI study. BMC Medical Ethics, 21 (1). doi:10.1186/s12910-020-00480-8

van Wijk, R. P. J., van Dijck, J. T. J. M., Timmers, M., van Veen, E., Citerio, G., Lingsma, H. F., Maas, A. I. R., Menon, D. K., Peul, W. C., Stocchetti, N., Kompanje, E. J. O., Åkerlund, C., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., Azouvi, P., ... The CENTER-TBI investigators and participants. (2020). Informed consent procedures in patients with an acute inability to provide informed consent: Policy and practice in the CENTER-TBI study. Journal of Critical Care, 59, 6-15. doi:10.1016/j.jcrc.2020.05.004

Voormolen, D. C., Polinder, S., von Steinbuechel, N., Feng, Y., Wilson, L., Oppe, M., Haagsma, J. A., Åkerlund, C., Adams, H., Amrein, K., Andelic, N., Andreassen, L., Anke, A., Antoni, A., Audibert, G., Azouvi, P., Azzolini, M. L., Bartels, R., Barzó, P., ... the CENTER-TBI participants and investigators. (2020). Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom. Quality of Life Research. doi:10.1007/s11136-020-02583-6

WALHIN, N., DULGHERU, R. E., Bonnet, P., PETITJEAN, H., RADERMECKER, A., LEGRAND, V., LANCELLOTTI, P., & RADERMECKER, M. (2018). HOCM/Sigmoid septum: mechanism and management of the obstruction. Journal of Cardiovascular Diseases, 1 (105), 2-5.

Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., Citerio, G., Coburn, M., Cooper, D. J., Crowder, A. T., Czeiter, E., Czosnyka, M., Diaz-Arrastia, R., Dreier, J. P., Duhaime, A.-C., ... Zumbo, F. (2017). Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. The Lancet Neurology, 16 (12), 987-1048. doi:10.1016/S1474-4422(17)30371-X

Pirlet, C., Pierard, L., Legrand, V., & Gach, O. (2017). Ratio of high-sensitivity troponin to creatine kinase-MB in takotsubo syndrome. International Journal of Cardiology. doi:10.1016/j.ijcard.2017.05.107

Radermecker, M., Martinez, C., Gach, O., Durieux, R., Defraigne, J.-O., & Legrand, V. (2016). CHOICE OF THE BEST TRANSCATHETER SITE FOR TAVI IMPLANTATION. Aorta. doi:10.12945/j.aorta.2016.16.500

Cnossen, M. C., Polinder, S., Lingsma, H. F., Maas, A. I. R., Menon, D., Steyerberg, E. W., Adams, H., Alessandro, M., Allanson, J., Amrein, K., Andaluz, N., Andelic, N., Andrea, N., Andreassen, L., Anke, A., Antoni, A., Ardon, H., Audibert, G., Auslands, K., ... Van Der Naalt, J. (2016). Variation in structure and process of care in traumatic brain injury: Provider profiles of European Neurotrauma Centers participating in the CENTER-TBI study. PLoS ONE, 11 (8). doi:10.1371/journal.pone.0161367

MEURICE, C., LEGRAND, V., & PIERARD, L. (2016). Apport du cathétérisme cardiaque dans le diagnostic et le traitement de la maladie coronarienne avant 40 ans. Revue Médicale de Liège, 71 (3), 129-136.

Radermecker, M., Lancellotti, P., Legrand, V., & Pierard, L. (2016). Delayed Asymptomatic Thrombosis and Erosion of the Coronary Sinus After Transvenous Mitral Annuloplasty With the Viacor Device. Annals of Thoracic Surgery, 101 (6), 2391. doi:10.1016/j.athoracsur.2016.01.073

LEGRAND, V. (March 2015). Angioplastie ou chirurgie chez le patient coronarien stable ? Revue du Praticien, 65 (3), 352-6.

Bartorelli, A. L., Egidy Assenza, G., Abizaid, A., Banning, A., Dzavik, V., Ellis, S., Gao, R., Holmes, D., Ho Jeong, M., LEGRAND, V., Neumann, F.-J., Spaulding, C., Worthley, S. G., & Urban, P. (2015). One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry. Catheterization and Cardiovascular Interventions. doi:10.1002/ccd.26026

Claeys, M. J., Coenen, S., Colpaert, C., Bilke, J., Beutels, P., Wouters, K., LEGRAND, V., Van Damme, P., & Vrints, C. (2015). Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population study. Acta Cardiologica, 70, 693-701. doi:10.2143/AC.70.6.3120182

Claeys, M. J., LEGRAND, V., Mairesse, G. H., Pasquet, A., De Pauw, M., & Van Camp, G. (2015). Summary 2014 ESC guidelines. Acta Cardiologica, 70 (1), 73-9. doi:10.1080/AC.70.1.3064596

Collas, V. M., Dubois, C., LEGRAND, V., Kefer, J., De Bruyne, B., Dens, J., Rodrigus, I. E., Herijgers, P., & Bosmans, J. M. (2015). Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry. Catheterization and Cardiovascular Interventions, 86 (3), 528-35. doi:10.1002/ccd.25999

Latib, A., Naganuma, T., Abdel-Wahab, M., Danenberg, H., Cota, L., Barbanti, M., Baumgartner, H., Finkelstein, A., LEGRAND, V., de Lezo, J. S., Kefer, J., Messika-Zeitoun, D., Richardt, G., Stabile, E., Kaleschke, G., Vahanian, A., Laborde, J.-C., Leon, M. B., Webb, J. G., ... Colombo, A. (2015). Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circulation. Cardiovascular Interventions, 8 (4). doi:10.1161/CIRCINTERVENTIONS.114.001779

Legrand, D., Barbato, E., Chenu, P., Magne, J., Vrolix, M., Wijns, W., & LEGRAND, V. (2015). The STIB score: a simple clinical test to predict clopidogrel resistance. Acta Cardiologica, 70, 522-527. doi:10.2143/AC.70.5.3110511

Thomas, M., Birkemeyer, R., Schwimmbeck, P., LEGRAND, V., Moreno, R., Briguori, C., Werner, N., Bramucci, E., Ungi, I., Richardt, G., Underwood, P., & Dawkins, K. (2015). One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 10, 1267-71. doi:10.4244/EIJY15M01_07

Zimmermann, F. M., Ferrara, A., Johnson, N. P., van Nunen, L. X., Escaned, J., Albertsson, P., Erbel, R., LEGRAND, V., Gwon, H.-C., Remkes, W. S., Stella, P. R., van Schaardenburgh, P., Bech, G. J. W., De Bruyne, B., & Pijls, N. (2015). Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. European Heart Journal, 36, 3182-3188. doi:10.1093/eurheartj/ehv452

LEMPEREUR, M., Magne, J., Cornelis, K., Hanet, C., Taeymans, Y., Vrolix, M., & LEGRAND, V. (2014). Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. doi:10.4244/EIJY14M12_11

Vrijens, B., Claeys, M. J., LEGRAND, V., Vandendriessche, E., & Van De Werf, F. (May 2014). Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). British Journal of Clinical Pharmacology, 77 (5), 746-755. doi:10.1111/bcp.12275

Linke, A., Wenaweser, P., Gerckens, U., Tamburino, C., Bosmans, J., Bleiziffer, S., Blackman, D., Schäfer, U., Müller, R., Sievert, H., Sondergaard, L., Klugmann, S., Hoffmann, R., Tchétché, D., Colombo, A., LEGRAND, V., Bedogni, F., lePrince, P., Schuler, G., ... Brecker, S. (2014). Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. European Heart Journal. doi:10.1093/eurheartj/ehu162

DAVIN, L., LEGRAND, V., LANCELLOTTI, P., PIERARD, L., & PITCHOT, W. (2014). When the heart has its reason: the Takotsubo Syndrome. Acta Psychiatrica Belgica.

GACH, O., Lempereur, M., Eeckhout, E., & Legrand, V. (2014). Unintentional "Ventriculo-Phlebo-Myo-Pericardiography". JACC. Cardiovascular Interventions. doi:10.1016/j.jcin.2013.07.024

LEGRAND, V., CUISSET, T., CHENU, P., VROLIX, M., MARTINEZ, C., DENS, J., GACH, O., BOLAND, J., CLAEYS, M., MAGNE, J., BARBATO, E., & WIJNS, W. (2014). Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 10, 204-211. doi:10.4244/EIJV10I2A34

Lenders, G. D., Collas, V., Hernandez, J. M., Legrand, V., Danenberg, H. D., den Heijer, P., Rodrigus, I. E., Paelinck, B. P., Vrints, C. J., & Bosmans, J. M. (2014). Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study. International Journal of Cardiology. doi:10.1016/j.ijcard.2014.07.092

PIRLET, C., Pierard, L., Lancellotti, P., Bruyere, R. P., NCHIMI LONGANG, A., Legrand, V., & DAVIN, L. (2014). Contribution du scanner coronaire au diagnostic de maladie coronarienne. Revue Médicale de Liège, 69 (7-8), 422-7.

Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., Legrand, V., Vrints, C., Vanoverschelde, J. L., Crespo-Diaz, R., Homsy, C., Tendera, M., Waldman, S., Wijns, W., & Terzic, A. (2013). Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE). Journal of the American College of Cardiology, 62 (25), 2454-6. doi:10.1016/j.jacc.2013.09.014

Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., Legrand, V., Vrints, C., Vanoverschelde, J. L., Crespo-Diaz, R., Homsy, C., Tendera, M., Waldman, S., Wijns, W., & Terzic, A. (2013). Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. Journal of the American College of Cardiology, 61 (23), 2329-38. doi:10.1016/j.jacc.2013.02.071

Claeys, M. J., Evrard, P., Gurné, O., Mairesse, G., Vandekerkhove, Y., De Sutter, J., & LEGRAND, V. (2013). Summary of 2012 ESC guidelines. Acta Cardiologica, 68, 71-75. doi:10.2143/AC.68.1.2959634

DAVIN, L., BRUYERE, P.-J., LANCELLOTTI, P., PIERARD, L., & Legrand, V. (2013). L'imagerie cardiovasculaire multimodalites avant l'implantation d'une prothese valvulaire aortique par voie percutanee. Revue Médicale de Liège, 68 (2), 86-93.

Gao, R., Abizaid, A., Banning, A., Bartorelli, A. L., Dzavik, V., Ellis, S., Jeong, M. H., Legrand, V., Spaulding, C., & Urban, P. (2013). One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry. Journal of Interventional Cardiology, 26 (2), 163-72. doi:10.1111/joic.12003

Sabate, M., Brugaletta, S., Abizaid, A., Banning, A., Bartorelli, A., Dzavik, V., Ellis, S., Holmes, D., Gao, R., Jeong, M. H., Legrand, V., Neumann, F.-J., Nyakern, M., Spaulding, C., Stoll, H.-P., Worthley, S., & Urban, P. (2013). Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry. International Journal of Cardiology, 168 (3), 2522-7. doi:10.1016/j.ijcard.2013.03.064

ERPICUM, M., Defraigne, J.-O., LARBUISSON, R., RADERMECKER, M., & LEGRAND, V. (2012). Nursing Care Plan for Transcatheter Aortic Valve Implantation with the Medtronic CoreValve Revalving® system. Liège, Belgium: Centre Hospitalier Universitaire de Liège.

Abizaid, A., Costa, J. R. J., Banning, A., Bartorelli, A. L., Dzavik, V., Ellis, S., Gao, R., Holmes, D. R. J., Jeong, M. H., Legrand, V., Neumann, F.-J., Nyakern, M., Orlick, A., Spaulding, C., Worthley, S., & Urban, P. M. (2012). The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. JACC. Cardiovascular Interventions, 5 (1), 64-71. doi:10.1016/j.jcin.2011.09.016

Budts, W., Legrand, V., Peeters, A., & Thijs, V. (2012). Management of patent foramen ovale in cryptogenic stroke. Acta Cardiologica, 67 (1), 3-9. doi:10.2143/AC.67.1.2146560

JAVILLIER, B., Jacquet, C., & Legrand, V. (2012). Une entite electrocardiographique peu connue, mais pourtant importante aux urgences ... le syndrome de Wellens. Revue Médicale de Liège, 67 (10), 527-30.

Martinez, C., Maazoun, Y., DURIEUX, R., Defraigne, J.-O., & Legrand, V. (2012). Endovascular repair of the left subclavian artery after gunshot wound: an alternative to surgical treatment. Acta Cardiologica, 67 (5), 609-12. doi:10.2143/AC.67.5.2174140

Worthley, S. G., Abizaid, A., Banning, A., Bartorelli, A., Dzavik, V., Ellis, S., Gao, R., Legrand, V., Urban, P., & Spaulding, C. (2012). One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry. Journal of Interventional Cardiology, 25 (3), 253-61. doi:10.1111/j.1540-8183.2011.00705.x

ERPICUM, M., RADERMECKER, M., DEFRAIGNE, J., & LEGRAND, V. (02 April 2011). Nursing care after Transcatheter Aortic Valve Implantation with the Medtronic CoreValve Revalving® system [Poster presentation]. 11th Annual Spring Meeting on Cardiovascular Nursing, Bruxelles, Belgium.

Bosmans, J. M., Kefer, J., De Bruyne, B., Herijgers, P., Dubois, C., Legrand, V., Verheye, S., & Rodrigus, I. (2011). Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interactive Cardiovascular and Thoracic Surgery, 12 (5), 762-7. doi:10.1510/icvts.2010.253773

Cuculi, F., Banning, A. P., Abizaid, A., Bartorelli, A. L., Baux, A. C., Dzavik, V., Ellis, S., Gao, R., Holmes, D., Jeong, M. H., Legrand, V., Neumann, F.-J., Nyakern, M., Spaulding, C., Stoll, H.-P., Worthley, S., & Urban, P. (2011). Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 7 (8), 962-8. doi:10.4244/EIJV7I8A152

Duckers, H. J., Houtgraaf, J., Hehrlein, C., Schofer, J., Waltenberger, J., Gershlick, A., Bartunek, J., Nienaber, C., Macaya, C., Peters, N., Smits, P., Siminiak, T., van Mieghem, W., Legrand, V., & Serruys, P. W. (2011). Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6 (7), 805-12. doi:10.4244/EIJV6I7A139

DULGUEROV, F., RADERMECKER, M., & LEGRAND, V. (2011). Options interventionnelles en matière de traitement moderne de la cardiomyopathie hypertrophique obstructive. Revue Médicale de Liège, 66 (1), 13-7.

Hong, Y. J., Jeong, M. H., Abizaid, A., Banning, A., Bartorelli, A., Dzavik, V., Ellis, S. G., Gao, R., Holmes, D. R. J., Legrand, V., Neumann, F.-J., Spaulding, C., Worthley, S., & Urban, P. (2011). Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry. JACC. Cardiovascular Interventions, 4 (9), 982-91. doi:10.1016/j.jcin.2011.06.013

Legrand, V. (2011). The Belgian Society of Cardiology: a view on its strength, weakness, opportunities and threats. Acta Cardiologica, 66 (2), 139-40. doi:10.2143/AC.66.2.2071242

Legrand, V., Garg, S., Serruys, P., Virtanen, K., Szurawitzki, G., Voudris, V., Fontanelli, A., Endersen, K., Kranjec, I., Rademaker, T., Stefanidis, C., & Wittebols, K. (2011). Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II). EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5, 838-845. doi:10.4244/EIJV6I7A144

Urban, P., Abizaid, A., Banning, A., Bartorelli, A. L., Baux, A. C., Dzavik, V., Ellis, S., Gao, R., Holmes, D., Jeong, M. H., Legrand, V., Neumann, F.-J., Nyakern, M., Spaulding, C., & Worthley, S. (2011). Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. Journal of the American College of Cardiology, 57 (13), 1445-54. doi:10.1016/j.jacc.2010.11.028

Le Goff, C., Garweg, C., Laurent, T., Kaux, J.-F., Deroyer, C., Merville, M.-P., Melon, P., Fillet, M., Legrand, V., & Chapelle, J.-P. (July 2010). Assessment of high sensitive troponin T and I immunoassays in patients with acute chest. Clinical Chemistry, 56 (S6), 127.

Claeys, M. J., Gevaert, S., de Meester, A., Evrard, P., Legrand, V., Vrints, C., Berkenboom, G., Desmet, W., Van Langenhove, G., Vranckx, P., Van de Werf, F., & Vandenbranden, F. (2010). Mise en pratique du traitement de reperfusion dans les infarctus du myocarde avec elevation du segment ST (STEMI). Recommandations actualisees de la Societe Belge de Cardiologie et de ses groupes de travail: le Groupe Interdisciplinaire de Cardiologie Aigue (BIWAC) et le Groupe de Cardiologie Interventionnelle (BWGIC). Revue Médicale de Bruxelles, 31 (1), 30-4.

Claeys, M. J., Gevaert, S., de Meester, A., Evrard, P., Legrand, V., Vrints, C., Berkenboom, G., Desmet, W., Van Langenhove, G., Vranckx, P., Van de Werf, F., & Vandenbranden, F. (2010). Mise en pratique du traitement de reperfusion dans les infarctus du myocarde avec elevation du segment ST. Revue Médicale de Liège, 65 (1), 23-8.

ERPICUM, M., DEFRAIGNE, J., LANCELLOTTI, P., LARBUISSON, R., MARTINEZ, C., PIERARD, L., RADERMECKER, M., LECLERCQ, V., & LEGRAND, V. (2010). Valve aortique percutanée. Urgences et Accueil, 11 (40), 6-8.

Legrand, D., & Legrand, V. (2010). Adhesion therapeutique aux antiagregants chez le patient coronarien. Revue Médicale de Liège, 65 (5-6), 304-10.

Moonen, M., Legrand, V., Lancellotti, P., Kassab, A., & Pierard, L. (October 2009). Traitement percutané d’une cardiomyopathie hypertrophique obstructive. Revue Médicale de Liège, 64 (10), 481.

Sack, S., Kahlert, P., Bilodeau, L., Pierard, L., Lancellotti, P., Legrand, V., Bartunek, J., Vanderheyden, M., Hoffmann, R., Schauerte, P., Shiota, T., Marks, D. S., Erbel, R., & Ellis, S. G. (August 2009). Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circulation. Cardiovascular Interventions, 2 (4), 277-84. doi:10.1161/CIRCINTERVENTIONS.109.855205

Gach, O., Louis, O., Chapelle, J.-P., Vanbelle, S., Pierard, L., & Legrand, V. (July 2009). Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart and Vessels, 24 (4), 267-70. doi:10.1007/s00380-008-1120-3

Austin, D., Oldroyd, K. G., Holmes, D. R. J., Rihal, C. S., Galbraith, P. D., Ghali, W. A., Legrand, V., Taeymans, Y., McConnachie, A., & Pell, J. P. (2009). Drug-eluting stents: a study of international practice. American Heart Journal, 158 (4), 576-84. doi:10.1016/j.ahj.2009.07.033

Bogaert, E., Bacher, K., Lemmens, K., Carlier, M., Desmet, W., De Wagter, X., Djian, D., Hanet, C., Heyndrickx, G., Legrand, V., Taeymans, Y., & Thierens, H. (2009). A large-scale multicentre study of patient skin doses in interventional cardiology: dose-area product action levels and dose reference levels. British Journal of Radiology, 82 (976), 303-12. doi:10.1259/bjr/29449648

Claessen, B. E., Beijk, M. A., Legrand, V., Ruzyllo, W., Manari, A., Varenne, O., Suttorp, M. J., Tijssen, J. G. P., Miquel-Hebert, K., Veldhof, S., Henriques, J. P. S., Serruys, P. W., & Piek, J. J. (2009). Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circulation. Cardiovascular Interventions, 2 (4), 339-47. doi:10.1161/CIRCINTERVENTIONS.108.831800.108.831800

Claeys, M. J., Gevaert, S., De Meester, A., Evrard, P., Legrand, V., Vrints, C., Berkenboom, G., Desmet, W., Van Langenhove, G., Vranckx, P., De Raedt, H., Van de Werf, F., & Van den Branden, F. (2009). Implementation of reperfusion therapy in ST-segment elevation myocardial infarction. A policy statement from the Belgian Society of Cardiology (BSC), the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) and the Belgian Working Group on Interventional Cardiology (BWGIC). Acta Cardiologica, 64 (4), 541-5. doi:10.2143/AC.64.4.2041621

Daemen, J., Simoons, M. L., Wijns, W., Bagust, A., Bos, G., Bowen, J. M., Braunwald, E., Camenzind, E., Chevalier, B., Dimario, C., Fajadet, J., Gitt, A., Guagliumi, G., Hillege, H. L., James, S., Juni, P., Kastrati, A., Kloth, S., Kristensen, S. D., ... Windecker, S. W. (2009). ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. European Heart Journal, 30 (2), 152-61. doi:10.1093/eurheartj/ehn510

Daemen, J., Simoons, M. L., Wijns, W., Bagust, A., Bos, G., Bowen, J. M., Braunwald, E., Camenzind, E., Chevaliers, B., DiMario, C., Fajadeto, J., Gitt, A., Guagliumi, G., Hillege, H. L., James, S., Juni, P., Kastrati, A., Kloth, S., Kristensen, S. D., ... Waliszewski, M. (2009). Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 4 (4), 427-36. doi:10.4244/EIJV4I4A75

DAVIN, L., Legrand, V., & Legrand, D. (2009). A frozen heart. European Heart Journal, 30 (15), 1827. doi:10.1093/eurheartj/ehp149

DUGAUQUIER, C., Hanssen, M., GACH, O., & Legrand, V. (2009). Elevation des biomarqueurs cardiaques apres un effort physique intense. Revue Médicale de Liège, 64 (7-8), 370-2.

Legrand, V. (2009). Anticorps monoclonaux en cardiologie. Revue Médicale de Liège, 64 (5-6), 310-2.

Nyssen, A.-S., Legrand, V., & Scheen, A. (2009). Risque de restenose et d'evenements cardiaques apres angioplastie coronaire chez le patient diabetique: reduction par des approches pharmacologiques systemiques. Revue Médicale de Liège, 64 (4), 192-8.

Nyssen, A., Legrand, V., & Scheen, A. (2009). Prévention de la resténose et des accidents cardiaques après angioplastie coronaire chez le diabétique. Revue Médicale de la Suisse Romande, 5, 1644-1649.

Nyssen, A., Legrand, V., & Scheen, A. (November 2008). Rapport benefice/risque des endoprotheses coronaires pharmaco-actives. 2ème partie : analyse dans la population diabétique. Revue Médicale de Liège, 63 (11), 654-661.

Daemen, J., Kuck, K. H., Macaya, C., Legrand, V., Vrolix, M., Carrie, D., Sheiban, I., Suttorp, M. J., Vranckx, P., Rademaker, T., Goedhart, D., Schuijer, M., Wittebols, K., Macours, N., Stoll, H. P., & Serruys, P. W. (2008). Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Journal of the American College of Cardiology, 52 (24), 1957-67. doi:10.1016/j.jacc.2008.09.010

Davin, L., Bruyere, P.-J., Gach, O., Legrand, V., Pierard, L., & Lancellotti, P. (2008). L'image du mois. Les valvules cardiaques en tomodensitometrie multidetecteur et echo 3D. Revue Médicale de Liège, 63 (10), 577-8.

Louvard, Y., Thomas, M., Dzavik, V., Hildick-Smith, D., Galassi, A. R., Pan, M., Burzotta, F., Zelizko, M., Dudek, D., Ludman, P., Sheiban, I., Lassen, J. F., Darremont, O., Kastrati, A., Ludwig, J., Iakovou, I., Brunel, P., Lansky, A., Meerkin, D., ... Lefevre, T. (2008). Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheterization and Cardiovascular Interventions, 71 (2), 175-83. doi:10.1002/ccd.21314

Maeyns, K., Legrand, V., Pierard, L., & Lancellotti, P. (2008). Antiagregants: doit-on les arreter avant un acte invasif? Revue Médicale de Liège, 63 (3), 136-40.

Nyssen, A., Legrand, V., & Scheen, A. (2008). Rapport benefice/risque des endoprotheses coronaires pharmaco-actives. 1ere partie: analyse dans la population generale. Revue Médicale de Liège, 63 (9), 542-8.

Nyssen, A., Legrand, V., & Scheen, A. (2008). Endoprotheses coronaires pharmaco-actives chez les patients diabetiques. Revue Médicale Suisse, 4 (168), 1806-10.

Davin, L., BRUYERE, P.-J., Lewin, M., Gach, O., Martinez, C., Ghaye, B., Legrand, V., & Pierard, L. (April 2007). Comment j'explore...Les arteres coronaires en 2007: apports de la tomodensitometrie. Revue Médicale de Liège, 62 (4), 222-9.

Limet, R., & Legrand, V. (March 2007). Strategies visant a diminuer le delai entre l'admission aux urgences et l'angioplastie coronaire: a propos d'un article recent du New England Journal of Medicine. Revue Médicale de Liège, 62 (3), 147-50.

Davin, L., Lewin, M., BRUYERE, P.-J., Gach, O., Martinez, C., Ghaye, B., Pierard, L., & Legrand, V. (2007). L'image du mois. Fistule coronaire en imagerie non invasive par CT scanner coronaire. Revue Médicale de Liège, 62 (7-8, Jul-Aug), 477-8.

Gach, O., Legrand, V., Biessaux, Y., Chapelle, J.-P., Vanbelle, S., & Pierard, L. (01 January 2007). Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. American Journal of Cardiology, 99 (1), 31-35. doi:10.1016/j.amjcard.2006.07.059

Jacquet, C. H., Radermecker, M., & Legrand, V. (2007). Le cas clinique du mois : “Le pouls alternant : un élément sémiologique rare de dysfonction ventriculaire gauche sévère”. Revue Médicale de Liège, 62, 132-134.

Legrand, V., Lancellotti, P., Waleffe, A., & Pierard, L. (2007). Actualites therapeutiques en cardiologie. Revue Médicale de Liège, 62 (5-6, May-Jun), 244-53.

Legrand, V., Thomas, M., Zelisko, M., De Bruyne, B., Reifart, N., Steigen, T., Hildick-Smith, D., Albiero, R., Darremont, O., Stankovic, G., Pan, M., Lassen, J. F., Louvard, Y., & Lefevre, T. (2007). Percutaneous coronary intervention of bifurcation lesions: state-of-the-art. Insights from the second meeting of the European Bifurcation Club. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3 (1), 44-9.

Breeman, A., Hordijk-Trion, M., Lenzen, M., Hoeks, S., Ottervanger, J. P., Bertrand, M. E., Sechtem, U., Zaliunas, R., Legrand, V., de Boer, M. J., Stahle, E., Mercado, N., Wijns, W., & Boersma, E. (November 2006). Treatment decisions in stable coronary artery disease: Insights from the Euro Heart Survey on Coronary Revascularization. Journal of Thoracic and Cardiovascular Surgery, 132 (5), 1001-1009. doi:10.1016/j.jtcvs.2006.05.051

Gach, O., Davin, L., & Legrand, V. (October 2006). Non-invasive imaging of a giant right coronary artery due to a coronary fistula. Acta Cardiologica, 61 (5), 569-571. doi:10.2143/AC.61.5.2017774

Breeman, A., de Boer, M. J., Bertrand, M. E., Wijns, W., Ottervanger, J. P., Boersma, E., Hoeks, S., Lenzen, M., Sechtem, U., & Legrand, V. (September 2006). Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care, 29 (9), 2003-2011. doi:10.2337/dc06-0118

Quaniers, J., Legrand, V., & Limet, R. (April 2006). L'image du mois. Un cas inhabituel d'insuffisance aortique aigue. Revue Médicale de Liège, 61 (4), 211.

LEGRAND, V., Kelbaek, H., Hauptmann, K. E., Glogar, D., Rutsch, W., Grollier, G., Vermeersch, P., Elias, J., & De Cock, C. C. (01 February 2006). Clinical and angiographic analysis with a Cobalt Alloy Coronary Stent (Driver) in stable and unstable angina pectoris. American Journal of Cardiology, 97 (3), 349-352. doi:10.1016/j.amjcard.2005.08.051

Cook, S., Togni, M., Walpoth, N., Maier, W., Muehlberger, V., LEGRAND, V., Milicic, D., Zambartas, C., Zelisko, M., Madsen, J. K., van Buuren, F., Lopez-Palop, R., Peeba, M., Koskenkorva, J., Vanhanen, H., Lablanche, J.-M., Lazaris, I., Géza, F., Eyjolfsson, K., ... Meier, B. (2006). Percutaneous coronary intervention in Europe 1992-2003. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1, 374-379.

Cook, S., Togni, M., Walpoth, N., Maier, W., Muehlberger, V., Legrand, V., Milicic, D., Zambartas, C., Zelizko, M., Madsen, J. K., van Buuren, F., Lopez-Palop, R., Peeba, M., Koskenkorva, J., Vanhanen, H., Lablanche, J.-M., Lazaris, I., Geza, F., Eyjolfsson, K., ... Meier, B. (2006). Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1 (4), 374-9.

Macaya, C., Garcia-Garcia, H. M., Colombo, A., Morice, M.-C., Legrand, V., Kuck, K.-H., Sheiban, I., Suttorp, M. J., Carrie, D., Vrolix, M., Wittebols, K., Stoll, H.-P., Donohoe, D., Bressers, M., & Serruys, P. W. (2006). One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 (1), 69-76.

Thomas, M., Hildick-Smith, D., Louvard, Y., Albiero, R., Darremont, O., Stankovic, G., Pan, M., Legrand, V., Debruyne, B., & Lefevre, T. (2006). Percutaneous coronary intervention for bifurcation disease.A consensus view from the first meeting of the European Bifurcation Club. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 (2), 149-53.

Konstam, M. A., Czerska, B., Bohm, M., Oren, R. M., Sadowski, J., Khanal, S., Abraham, W. T., Wasler, A., Dahm, J. B., Gavazzi, A., Gradinac, S., Legrand, V., Mohacsi, P., Poelzl, G., Radovancevic, B., Van Bakel, A. B., Zile, M. R., Cabuay, B., Bartus, K., & Jansen, P. (15 November 2005). Continuous aortic flow augmentation - A pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation, 112 (20), 3107-3114. doi:10.1161/CIRCULATIONAHA.105.555367

Legrand, V., Doneux, P., Martinez, C., Gach, O., & Bellekens, M. (October 2005). Femoral access management: comparison between two different vascular closure devices after percutaneous coronary intervention. Acta Cardiologica, 60 (5), 482-488. doi:10.2143/AC.60.5.2004968

Gach, O., Pierard, L., & Legrand, V. (April 2005). Inflammation et atherosclerose: etat de la question en 2004-2005. Revue Médicale de Liège, 60 (4), 235-41.

Lemos, P. A., Serruys, P. W., de Feyter, P., Mercado, N. F., Goedhart, D., Saia, F., Arampatzis, C. A., Soares, P. R., Ciccone, M., Arquati, M., Cortellaro, M., Rutsch, W., & Legrand, V. (15 February 2005). Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy). American Journal of Cardiology, 95 (4), 445-451. doi:10.1016/j.amjcard.2004.10.008

legrand, D., & Legrand, V. (2005). La maladie coronarienne diabetique. Revue Médicale de Liège, 60 (5-6), 526-30.

Gach, O., Pierard, L., & Legrand, V. (November 2004). Image du mois. Fibrodysplasie musculaire de l'artère rénale. Revue Médicale de Liège, 59 (11), 624-5.

Legrand, V. (April 2004). L'angor. Revue Médicale de Liège, 59 (4), 186-9.

Scheen, A., Warzee, F., & Legrand, V. (2004). Drug-eluting stents: meta-analysis in diabetic patients. European Heart Journal, 25 (23), 2167-8; author reply 2168-9. doi:10.1016/j.ehj.2004.07.041

Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique. Partie 3: Nouvelles perspectives apportees par les stents enrobes. Revue Médicale de Liège, 59 (12), 711-6.

Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique. Partie 2: Espoirs apportes par les protheses endovasculaires. Revue Médicale de Liège, 59 (11), 653-8.

Warzee, F., Legrand, V., & Scheen, A. (2004). Angioplastie percutanee coronaire chez le patient diabetique Partie 1 : echecs relatifs lies a la restenose apres angioplastie simple. Revue Médicale de Liège, 59 (10), 584-90.

Gach, O., Troisfontaines, P., & LEGRAND, V. (October 2003). Le cas clinique du mois. Precordialgies evoquant un syndrome coronaire instable, un ecueil diagnostique. Revue Médicale de Liège, 58 (10), 611-4.

Liu, X. S., Huang, Y. M., Hanet, C., Vandormael, M., Legrand, V., Dens, J., Vandenbossche, J. L., Missault, L., Vrints, C., & De Scheerder, I. (October 2003). Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial. Catheterization and Cardiovascular Interventions, 60 (2), 172-178. doi:10.1002/ccd.10636

Gach, O., Louis, O., Martinez, C., Lambermont, B., Gérard, P., & Legrand, V. (August 2003). Predictors of early and late outcome of percutaneous coronary intervention in octogenarians. Acta Cardiologica, 58 (4), 289-294. doi:10.2143/AC.58.4.2005285

Legrand, V., Wijns, W., Vandenbranden, F., Benit, E., Boland, J., Claeys, M., De Scheerder, I., Eemans, T., Hanet, C., Heyndrickx, G., Lafontaine, P., Materne, P., Taeymans, Y., Vrints, C., & Vrolix, M. (August 2003). Guidelines for percutaneous coronary intervention by the Belgian Working Group on Invasive Cardiology. Acta Cardiologica, 58 (4), 341-348. doi:10.2143/AC.58.4.2005292

Legrand, V., Gach, O., & Martinez, C. (May 2003). Prevention secondaire apres syndrome coronarien aigu. Revue Médicale de Liège, 58 (5), 279-82.

Gach, O., Troisfontaines, P., & LEGRAND, V. (March 2003). L'image du mois. Artere coronaire unique ou tronc commun occlus collateralise? Revue Médicale de Liège, 58 (3), 117-8.

Scheen, A., & Legrand, V. (2003). L'etude clinique du mois. L'etude EUROPA: protection cardio-vasculaire avec le perindopril chez les patients avec coronaropathie stable. Revue Médicale de Liège, 58 (11), 713-6.

Gach, O., & Legrand, V. (December 2002). Le cas clinique du mois. Decouverte fortuite d'une fistule coronarienne. Revue Médicale de Liège, 57 (12), 757-9.

Mauri, L., Bonan, R., Weiner, B. H., Legrand, V., Bassand, J. P., Popma, J. J., Niemyski, P., Prpic, R., Ho, K. K. L., Chauhan, M. S., Cutlip, D. E., Bertrand, O. F., & Kuntz, R. E. (15 November 2002). Cutting balloon angioplasty for the prevention of restenosis: Results of the cutting balloon global randomized trial. American Journal of Cardiology, 90 (10), 1079-1083. doi:10.1016/S0002-9149(02)02773-X

Serruys, P. W., Foley, D. P., Suttorp, M. J., Rensing, B. J. W. M., Suryapranata, H., Materne, P., van den Bos, A., Benit, E., Anzuini, A., Rutsch, W., Legrand, V., Dawkins, K., Cobaugh, M., Bressers, M., Backx, B., Wijns, W., & Colombo, A. (2002). A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. Journal of the American College of Cardiology, 39 (3), 393-9. doi:10.1016/S0735-1097(01)01760-0

Abizaid, A., Costa, M. A., Centemero, M., Abizaid, A. S., Legrand, V., Limet, R. V., Schuler, G., Mohr, F. W., Lindeboom, W., Sousa, A. G., Sousa, J. E., van Hout, B., Hugenholtz, P. G., Unger, F., & Serruys, P. W. (2001). Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation, 104 (5), 533-8. doi:10.1161/hc3101.093700

Anzuini, A., Briguori, C., Rosanio, S., Tocchi, M., Pagnotta, P., Bonnier, H., Gimelli, G., Airoldi, F., Margonato, A., Legrand, V., & Colombo, A. (2001). Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings. American Journal of Cardiology, 88 (11), 1246-50. doi:10.1016/S0002-9149(01)02085-9

Chapelle, J.-P., Legrand, V., Lutteri, L., & Gielen, J. (2001). Cardiac troponin I and T concentrations are related to plasma lipoprotein (a) levels in PTCA patients. European Heart Journal, 22, 209.

Foley, D. P., Pieper, M., Wijns, W., Suryapranata, H., Grollier, G., Legrand, V., de Scheerder, I., Hanet, C., Puel, J., Mudra, H., Bonnier, H. J., Colombo, A., Thomas, M., Probst, P., Morice, M., Kleijne, J., & Serruys, P. W. (2001). The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L Study. European Heart Journal, 22 (17), 1585-93. doi:10.1053/euhj.2001.2752

Kiemeneij, F., Serruys, P. W., Macaya, C., Rutsch, W., Heyndrickx, G., Albertsson, P., Fajadet, J., Legrand, V., Materne, P., Belardi, J., Sigwart, U., Colombo, A., Goy, J. J., Disco, C. M., & Morel, M. A. (2001). Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. Journal of the American College of Cardiology, 37 (6), 1598-603. doi:10.1016/S0735-1097(01)01207-4

Legrand, V. (2001). Ionic or non-ionic contrast media during coronary intervention: does it make a difference? European Heart Journal, 22 (5), 353-4. doi:10.1053/euhj.2000.2447

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Relationship between lipoprotein (a) and cardiac troponins in PTCA patients. Acta Clinica Belgica, 56, 325.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients. Clinical Chemistry and Laboratory Medicine, 39 (suppl), 278.

Chapelle, J.-P., Biessaux, Y., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Heart, 83 (suppl. II), 24.

Chapelle, J.-P., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Clinical Chemistry, 46 (suppl), 82.

Vrolix, M. C., Legrand, V., Reiber, J. H., Grollier, G., Schalij, M. J., Brunel, P., Martinez-Elbal, L., Gomez-Recio, M., Bar, F. W., Bertrand, M. E., Colombo, A., & Brachman, J. (2000). Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. American Journal of Cardiology, 86 (4), 385-9. doi:10.1016/S0002-9149(00)00951-6

Chapelle, J.-P., Gielen, J., Legrand, V., & Lutteri, L. (1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay. Clinical Chemistry and Laboratory Medicine, 37 (suppl), 373.

Anzuini, A., Rosanio, S., Legrand, V., Tocchi, M., Coppi, R., Bonnier, H., Sheiban, I., Kulbertus, H., & Chierchia, S. L. (1998). Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience. Journal of the American College of Cardiology, 31 (2), 281-8. doi:10.1016/S0735-1097(97)00490-7

Bertrand, M. E., Legrand, V., Boland, J., Fleck, E., Bonnier, J., Emmanuelson, H., Vrolix, M., Missault, L., Chierchia, S., Casaccia, M., Niccoli, L., Oto, A., White, C., Webb-Peploe, M., Van Belle, E., & McFadden, E. P. (1998). Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation, 98 (16), 1597-603. doi:10.1161/01.CIR.98.16.1597

Marechal, P., Legrand, V., Chapelle, J.-P., & Kulbertus, H. (1998). The clinical signification of troponin T, troponin I, CK and CK-MB after coronary angioplsaty. Acta Cardiologica, 53, 319.

Vos, J., de Feyter, P. J., Kingma, J. H., Emanuelsson, H., Legrand, V., Winkelmann, B., Dumont, J. M., & Simoons, L. M. (1997). Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators. European Heart Journal, 18 (7), 1081-9. doi:10.1093/oxfordjournals.eurheartj.a015401

Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., & Materne, P. (1994). A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. New England Journal of Medicine, 331 (8), 489-95. doi:10.1056/NEJM199408253310801

Bates, E. R., Aueron, F. M., Legrand, V., LeFree, M. T., Mancini, G. B., Hodgson, J. M., & Vogel, R. A. (1985). Comparative long-term effects of coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty on regional coronary flow reserve. Circulation, 72 (4), 833-9. doi:10.1161/01.CIR.72.4.833

Mancini, G. B., Hodgson, J. M., Legrand, V., Bates, E. R., Aueron, F. M., LeFree, M. T., Smith, J. S., Beauman, G. J., & Vogel, R. A. (1985). Quantitative assessment of global and regional left ventricular function with low-contrast dose digital subtraction ventriculography. CHEST, 87 (5), 598-602. doi:10.1378/chest.87.5.598

Legrand, V., Chevigne, M., Foulon, J., & Rigo, P. (1983). Evaluation of right-ventricular function by gated blood-pool scintigraphy. Journal of Nuclear Medicine, 24 (10), 886-93.

Legrand, V., Deliege, M., Henrard, L., Boland, J., & Kulbertus, H. (1982). Patients with myocardial infarction and normal coronary arteriogram. CHEST, 82 (6), 678-85. doi:10.1378/chest.82.6.678

Demoulin, J. C., Bertholet, M., Chevigne, M., Legrand, V., Renier, J., Soumagne, D., Soyeur, D., Limet, R., & Kulbertus, H. (1981). Prognostic significance of electrocardiographic findings in angina at rest. Therapeutic implications. British Heart Journal, 46 (3), 320-4. doi:10.1136/hrt.46.3.320